Scilex Holding Company (SCLX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 2.56 |
| Open | 2.53 |
| Day High | 2.65 |
| Day Low | 2.52 |
| 52-Week High | 27 |
| 52-Week Low | 2.51 |
| Volume | 7,580.09 |
| Average Volume | 48,125 |
| Market Cap | 17.87M |
| PE | -0.07 |
| EPS | -38.95 |
| Moving Average 50 Days | 4.75 |
| Moving Average 200 Days | 5.52 |
| Change | -0.02 |
Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets
GlobeNewswire Inc.
Jan 30, 2026 2:00 PM GMT
PALO ALTO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management product
Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel
GlobeNewswire Inc.
Jan 02, 2026 2:00 PM GMT
PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management product
Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.
GlobeNewswire Inc.
Dec 23, 2025 2:00 PM GMT
PALO ALTO, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management product